Reduced medication costs by up to 78.5% for 544 medicines as announced by the Ministry of Health
In a recent announcement, Kuwait's Minister of Health, Ahmad Al-Awadhi, unveiled a significant price reduction on 544 medicines and medical products. These reductions, part of a continuous national policy, aim to improve healthcare affordability and economic efficiency.
The price adjustments cover essential drugs for a variety of conditions, including cancer, diabetes, hypertension, cholesterol, asthma, arthritis, skin diseases, and colon diseases. Notably, 144 of these medicines now have prices among the lowest in the Gulf region.
Some of the specific notable cuts include the weight-loss injection Tirzepatide (Mounjaro) reduced by 30%, diabetes drug Wegovy by 37.3%, and obesity drug Saxenda by 20.8%.
This initiative follows previous price adjustments made in March and July 2025 and is a testament to Kuwait's commitment to providing essential medicines at reasonable prices for both citizens and residents.
The Ministry of Health emphasizes ongoing monitoring to regulate prices on essential medicines as part of an overall strategy for sustainable healthcare cost management. The new prices for 144 key drugs are based on being the lowest in the Gulf region, with the ministry releasing new price quotations for these drugs.
The list of price-reduced medicines and medical products includes antibiotics, furthering the accessibility of necessary healthcare resources. This move is expected to promote economic sustainability within the healthcare sector and make healthcare more affordable and sustainable.
The Ministry of Health in Kuwait remains committed to ensuring affordable medications for both citizens and residents, underscoring its commitment to affordable and sustainable healthcare. This initiative aims to keep treatments affordable and accessible, contributing to a healthier population in Kuwait.
The initiative by Kuwait's Ministry of Health focuses on making medications more affordable for various health and wellness issues, including cancer, diabetes, and digestive health conditions such as colon diseases. Additionally, the new pricing for 144 key drugs includes treatments for skin conditions, demonstrating a commitment to addressing a broad spectrum of medical-conditions. The ministry's ongoing monitoring and price adjustments are aimed at ensuring sustainability in healthcare cost management, with an emphasis on making health and wellness resources accessible, such as antibiotics, for all citizens and residents.
